EUVIMED · CrossrefJournal
Oncology
ISSN 0030-2414 · S. Karger AG
Latest articles
Genomic and Clinical Impact of Smoking on Therapeutic Outcomes in Colorectal Cancer: A Public Databases Analysis
Survival Differences Between De Novo and Recurrent HER2-Positive Metastatic Breast Cancer: A Systematic Review and Meta-Analysis
Risk Factors for Central and Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study
Comparison of quality of life between docetaxel and weekly paclitaxel in the neoadjuvant or adjuvant treatment of breast cancer
Usefulness of the Lymphocyte-to-Monocyte Ratio in Predicting Prognosis in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
Practical Guide for Managing Philadelphia-Negative Myeloproliferative Neoplasms in Patients with Organ Dysfunction
Fat Mass and Survival in Immunotherapy-Treated Metastatic Renal Cell Carcinoma Patients
Unique Stroma of Higher-Grade Pancreatic Intraepithelial Neoplasia: Fibroblastic Cluster Formation and CD36 Downregulation
Emergency Department Visits after Radiotherapy in Patients with Solid Malignancies: Analysis of Causality and Severity
Hydroxyurea Bridging Before Frontline Tyrosine Kinase Inhibitor Therapy in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: A Critical Appraisal
Real-World Outcomes in Acute Promyelocytic Leukemia: A 13-Year Cohort from Qatar
SF3A3 in Liver Hepatocellular Carcinoma: Oncogenic Role and Prognostic Significance
FLAG-Based versus Standard 7+3 Induction Therapy in Adults with Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
The Prognostic PLECH Score in Mesothelioma
Longitudinal Changes in Body Weight and Body Mass Index in Patients with Chronic-Phase Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors: A Retrospective Observational Study
Rising Lung Cancer Burden Attributable to High Fasting Plasma Glucose in Women Aged ≥50 Years: Age-, SDI-, and BRICS-Specific Patterns from GBD 1990–2021
Diagnostic Pathways and Outcomes of First-Line Atezolizumab plus Bevacizumab in Patients with Locoregional Therapy-Ineligible Hepatocellular Carcinoma at Initial Diagnosis
Retrospective Comparison of Capecitabine plus Oxaliplatin and Docetaxel plus S-1 as Adjuvant Chemotherapy for Pathological Stage III Gastric Cancer
Association between Clinicopathological Features and BRAF V600E Mutation in Papillary Thyroid Carcinoma: A Meta-Analysis and Systematic Review
The Initial Therapeutic Response in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Contributes to the Change of Liver Function during Treatment: A Multicenter Analysis
Treatment Outcomes in Frail Patients with Advanced Pancreatic Ductal Adenocarcinoma: A Real-World Comparison of Gemcitabine, S-1, and Stereotactic Ablative Radiotherapy
Intratumoral Hemorrhage Induced by Atezolizumab plus Bevacizumab Combination Therapy in Patients with Hepatocellular Carcinoma
Predicting Early Metastasis in Extremity and Trunk Sarcomas: A Retrospective Analysis of 344 Patients
Association of Hypoglycemic Agents with the Risk of Platinum-Based Chemotherapy-Induced Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus
Serum MicroRNA-122 Predicts Early Progressive Disease in Unresectable Hepatocellular Carcinoma with Atezolizumab plus Bevacizumab Therapy
Hypoxia-Induced MicroRNAs Confer Survival Advantage in Bladder Cancer by Fine-Tuning Oncogenic Pathways
Transforming Acute Myeloid Leukemia Care through Precision Medicine: Integrating Genomic Profiling, Measurable Residual Disease, and Targeted Therapies
Can Splenic Characteristics Predict Rectal Cancer Chemotherapy Toxicity and Treatment Outcomes in Rectal Cancer Patients?
Nivolumab versus Best Supportive Care after Failure of Chemotherapy in Non-Small Cell Lung Cancer Patients with ECOG 3 or 4: A Propensity-Matched Analysis
Association between Antibiotic Exposure and the Risk of Checkpoint Inhibitor Pneumonitis in Lung Cancer Patients
Volumes
2026 · 712025 · 1132024 · 1952023 · 1092022 · 932021 · 1082020 · 1372019 · 1042018 · 1242017 · 1552016 · 1192015 · 1362014 · 1232013 · 1432012 · 1142011 · 1482010 · 1532009 · 2912008 · 1122007 · 1692006 · 1372005 · 1782004 · 1502003 · 1682002 · 1572001 · 1382000 · 1291999 · 1371998 · 1051997 · 1051996 · 971995 · 951994 · 1021993 · 1151992 · 1191991 · 1041990 · 1021989 · 911988 · 1031987 · 83
EUVIMED